PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $74,868 | -12.5% | 24,229 | +19.8% | 0.00% | 0.0% |
| Q4 2022 | $85,522 | -25.0% | 20,218 | +63.2% | 0.00% | -50.0% |
| Q2 2021 | $114,000 | +11.8% | 12,385 | +17.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -5.6% | 10,539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $108,000 | +1.9% | 10,539 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $106,000 | -3.6% | 10,539 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $110,000 | +23.6% | 10,539 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $89,000 | -80.9% | 10,539 | -80.2% | 0.01% | -82.9% |
| Q4 2019 | $466,000 | -32.9% | 53,289 | -17.4% | 0.04% | -35.9% |
| Q3 2019 | $695,000 | -75.1% | 64,532 | +102.3% | 0.06% | -89.0% |
| Q2 2017 | $2,788,000 | – | 31,900 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |